Two-year effects of semaglutide in adults with overweight or obesity

Human Clinical2022human clinicalSemaglutide

Garvey et al. · Nature Medicine

External database identifiers for this reference are being curated. Use the lookup links above to retrieve the full record from PubMed or Google Scholar.

Abstract / Summary

Clarifies complex ongoing cardiometabolic progression matrices continuously improving across massively extended strictly observed clinical application timelines.

Methods

Investigated as a human clinical in the field of metabolic research. The study design follows the methodology described in the published manuscript indexed under the identifiers listed above. Full methodological detail is available in the source publication via the PubMed or DOI link.

Results

Clarifies complex ongoing cardiometabolic progression matrices continuously improving across massively extended strictly observed clinical application timelines.

Limitations

Necessitates massive sustained pharmaceutical commitment protocols absent in basic basic research.

External links